COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Monthly Archives:
September 2013

30

September
2013

category:

503b Compounding

H.R. 3204 – 42% chance of being enacted

Status This bill passed in the House on September 28, 2013 and goes to the Senate next for consideration. Progress Introduced Sep 27, 2013 Referred to Committee Sep 27, 2013 Passed House Sep 28, 2013 Passed Senate … Signed by the President … Prognosis 42% chance of being enacted.https://www.govtrack.us/congress/bills/113/hr3204

read more

30

September
2013

category:

503b Compounding

BGOV Bill Summary: H.R. 3204, Drug Compounding and Supply Safety

(Bloomberg) — The Food and Drug Administration’s oversight of compounded drugs would be expanded and the U.S. for the first time would have uniform standards to monitor drug distribution from factories to pharmacies under H.R. 3204. The bill, which reflects an informal House-Senate agreement on the issues, would allow the FDA to collect and spend […]

read more

30

September
2013

category:

503b Compounding

Use of Propofol In Executions Could Result In Anesthetic Shortage, EU Sanctions

The state of Missouri plans to execute a death row inmate next month using for the first time a lethal dose of the widely-used anesthesia drug propofol. The European Union (EU), where most of the U.S. propofol supply is manufactured and capital punishment is banned, is warning that export sanctions may be imposed on the […]

read more